Immediate Impact
12 from Science/Nature 65 standout
Citing Papers
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
2022 Standout
Works of Susan Ayres being referenced
Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Susan Ayres | 19 | 15 | 18 | 207 | 172 | 18 | 334 | |
| Michael Pascual | 10 | 35 | 47 | 138 | 100 | 10 | 310 | |
| Barbara Piccini | 4 | 5 | 12 | 93 | 143 | 32 | 346 | |
| Paula Andrea Díaz Valencia | 13 | 6 | 12 | 101 | 157 | 19 | 310 | |
| David Martinez Garza | 18 | 6 | 11 | 120 | 172 | 12 | 306 | |
| Joanna Cobb | 33 | 23 | 18 | 32 | 60 | 18 | 369 | |
| J. M. Russell | 10 | 6 | 71 | 27 | 161 | 15 | 351 | |
| Wilson M. Alobuia | 55 | 31 | 44 | 62 | 23 | 19 | 329 | |
| Bastian Salewsky | 4 | 4 | 26 | 55 | 49 | 15 | 284 | |
| Jennifer C. Dunn | 9 | 25 | 7 | 210 | 114 | 17 | 331 | |
| Yasuo Haruki | 27 | 10 | 43 | 44 | 35 | 32 | 359 |
All Works
Login with ORCID to disown or claim papers
Loading papers...